Chronic spontaneous urticaria (CSU) Program in Pharmaceutical Benefits Scheme (PBS) 012-18051109
Expand allCSU restriction and item codes
Do not share this attachment externally. See Freedom of information - Information Publication Scheme.
PBS CSU restriction and item codes
FAQs from Service Officers
Table 1: see Table 2 in Processing Complex Authority Required Listings for FAQs about all Complex programs.
|
Item |
Description |
|
1 |
Can an increase in quantity be approved if a higher dose is required? Yes. If the OPA system does not reject the quantity requested, an increase can be approved based on a higher monthly dose. If OPA rejects the quantity requested, escalate to a PA. |
|
2 |
What type of application should be submitted for a patient who ceases therapy and relapses? Any patient who ceases therapy and whose CSU relapses will need to re-initiate PBS-subsidised omalizumab as a new patient, meeting all initial PBS criteria again. |